Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint ReviewJason D. Merker, Nicholas C. Turner, Geoffrey R. Oxnard et al.|Journal of Clinical Oncology|2018Cited by 925
American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment OptionsLowell E. Schnipper, Richard L. Schilsky, Adam P. Dicker et al.|Journal of Clinical Oncology|2015Cited by 903
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With <i>KRAS</i> Wild-Type Advanced or Metastatic Colorectal CancerAlan P. Venook, Charles D. Blanke, Donna Niedzwiecki et al.|JAMA|2017Cited by 891
Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)Hedy L. Kindler, Richard M. Goldberg, Donna Niedzwiecki et al.|Journal of Clinical Oncology|2010Cited by 840
Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments ReceivedLowell E. Schnipper, Richard L. Schilsky, Nancy E. Davidson et al.|Journal of Clinical Oncology|2016Cited by 654